The project concerns the development of novel diagnostic tests that can be used on the existing platform. The main focus will be on diagnostic tests relevant for (i) diabetes, (ii) cardiac and (iii) metabolic diseases. Furthermore this project includes the necessary investments to upscale the manufacturing capacities based on the increased product portfolio and market demand.